(VIANEWS) - Blackstone GSO Long Short Credit Income Fund (BGX), NVE Corporation (NVEC), Blackrock MuniYield Pennsylvania Quality Fund (MPA) have the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Blackstone GSO Long Short Credit Income Fund (BGX) | 11.18 | -0.36% | 8.42% | 2022-11-19 23:15:06 |
| 2 | NVE Corporation (NVEC) | 65.99 | 1.93% | 6% | 2022-11-11 01:43:15 |
| 3 | Blackrock MuniYield Pennsylvania Quality Fund (MPA) | 10.32 | 0.39% | 4.88% | 2022-11-04 21:07:21 |
| 4 | Rayonier REIT (RYN) | 32.88 | 4.02% | 3.47% | 2022-11-05 22:23:06 |
| 5 | Bristol (BMY) | 77.54 | 0.49% | 2.93% | 2022-11-20 03:13:28 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Blackstone GSO Long Short Credit Income Fund (BGX) - Dividend Yield: 8.42%
Blackstone GSO Long Short Credit Income Fund's last close was $11.18, 26.93% below its 52-week high of $15.30.
The Blackstone / GSO Long Short Credit Income Fund, a closed-ended fixed-income mutual fund that was launched by The Blackstone Group LP is Blackstone / GSO Long Credit Income Fund. GSO/Blackstone Debt Funds Management LLC manages the fund. The fund can be invested in both fixed-income markets in the United States by taking long or short positions. This fund invests in stocks from companies that operate across diverse sectors. The fund invests primarily in fixed-income and loans of corporate issuers. This includes first and second lien secured loan, and high yield corporate debt securities with varying maturities. It invests in securities that are not considered investment-grade. To create its portfolio, it uses fundamental analysis and a credit-driven research approach. It compares its portfolio's performance to a composite index that includes 70% S&P/LSTA Loan Index and 30% Barclays US High Yield Index. The fund was previously known as Blackstone/GSO Dynamic Credit Income Fund. Blackstone/GSO Long-Short Credit Income Fund is a new entity that was established on 22 October 2010. Its headquarters are in the United States.
Earnings per Share
Blackstone GSO Long Short Credit Income Fund's trailing 12-month EPS is $1.31.
PE Ratio
Blackstone GSO Long Short Credit Income Fund's trailing 12-month price-earnings ratio is 8.53. The purchaser of the shares is therefore investing $8.53 per dollar in annual earnings.
Yearly Top and Bottom Value
Blackstone GSO Long Short Credit Income Fund's stock is valued at $11.18 at 09:16 EST, way under its 52-week high of $15.30 and above its 52-week low of $10.58.
Volatility
Blackstone GSO Long Short Credit Income Fund's last week, last month's, and last quarter's current intraday variation average was 0.18%, 0.24%, and 0.90%.
Blackstone GSO Long Short Credit Income Fund's highest amplitude of average volatility was 0.72% (last week), 0.92% (last month), and 0.90% (last quarter).
More news about Blackstone GSO Long Short Credit Income Fund.
2. NVE Corporation (NVEC) - Dividend Yield: 6%
NVE Corporation's last close was $65.99, 12.6% below its 52-week high of $75.50.
NVE Corporation designs and sells products that utilize spintronics. This is a type of nanotechnology that uses electron spin to obtain, store and transmit data in the United States as well as internationally. It manufactures sensors and couplers that enable data acquisition and transmission. The company's sensors detect magnetic material and determine speed. It produces standard sensors that are used in factory automation markets. Custom and medical sensors can be used to replace electromechanical magnet switches. Spintronic couplers are also offered by the company for use in industrial Internet of Things. It also engages in spintronic magnetoresistive random-access memory technology research, development and licensing. NVE Corporation was established in 1989. It is located in Eden Prairie in Minnesota.
Earnings Per Share
As for profitability, NVE Corporation has a trailing twelve months EPS of $2.47.
PE Ratio
NVE Corporation has a trailing twelve months price to earnings ratio of 26.76. Meaning, the purchaser of the share is investing $26.76 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.54%.Revenue growth
The year-over-year growth in quarterly revenue was 57.1%. We now have 31.06M in the 12 trailing months.
Volume
NVE Corporation's latest reported volume is 21205, which is 20.73% more than its average volume (17563)
More news about NVE Corporation.
3. Blackrock MuniYield Pennsylvania Quality Fund (MPA) - Dividend Yield: 4.88%
Blackrock MuniYield Pennsylvania Quality Fund's last close was $10.32, 41.03% under its 52-week high of $17.50.
BlackRock MuniYield Pennsylvania Quality Fund, a closed-ended fixed income mutual fund, was launched in 2011 by BlackRock, Inc. BlackRock Advisors, LLC manages the fund. It invests in fixed-income markets. The fund invests in municipal bonds of high investment quality that are exempted from income tax and federal income taxes. It also holds short-term bonds and investments. BlackRock MuniYield Pennsylvania Quality Fund was established in 1992. It is based in the United States.
Earnings Per Share
As for profitability, Blackrock MuniYield Pennsylvania Quality Fund has a trailing twelve months EPS of $0.64.
PE Ratio
Blackrock MuniYield Pennsylvania Quality Fund has a trailing twelve months price to earnings ratio of 16.12. Meaning, the purchaser of the share is investing $16.12 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -1.59%.Volume
Today's last reported volume for Blackrock MuniYield Pennsylvania Quality Fund is 51041 which is 70.18% above its average volume of 29992.
Yearly Top and Bottom Value
Blackrock MuniYield Pennsylvania Quality Fund's stock is valued at $10.32 at 09:21 EST, way below its 52-week high of $17.50 and above its 52-week low of $10.17.
More news about Blackrock MuniYield Pennsylvania Quality Fund.
4. Rayonier REIT (RYN) - Dividend Yield: 3.47%
Rayonier REIT's last close was $32.88, 28.32% below its 52-week high of $45.87.
Rayonier, a top timberland investment trust that focuses on timberland property and has assets in some of New Zealand's most productive timber growing areas. Rayonier owned, leased or sublet under long-term contracts approximately 2.75 million acres of timberlands in the U.S. South (1.7 million acres), U.S. Pacific Northwest (550,000 acres) and New Zealand (4117,000 acres). Rayonier also serves as managing member of a private timber investment fund with three funds totaling around 141,000 acres. The Company owns approximately 17,000 acres of the timber fund business on an A"look-through basisA.
Earnings Per Share
As for profitability, Rayonier REIT has a trailing twelve months EPS of $0.55.
PE Ratio
Rayonier REIT has a trailing twelve months price to earnings ratio of 59.78. Meaning, the purchaser of the share is investing $59.78 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.69%.Growth Estimates Quarters
The company's growth estimates for the ongoing quarter is 1100% and a drop 15% for the next.Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 14, 2022, the estimated forward annual dividend rate is 1.14 and the estimated forward annual dividend yield is 3.47%.
Annual Top and Bottom Value
Rayonier REIT stock was valued at $32.88 as of 09:22 EST. This is way below its 52 week high of $45.87, and far above its 52 week low of $29.51.
More news about Rayonier REIT.
5. Bristol (BMY) - Dividend Yield: 2.93%
Bristol's last close was $77.45, 3.9% below its 52-week high of $80.59.
The Bristol-Myers Squibb Company develops, licenses and manufactures biopharmaceutical product worldwide. The company offers products in hematology and oncology as well as cardiovascular, immunology (fibrotic), neuroscience, covid-19, and other areas. Revlimid is an oral immunomodulatory drug that treats multiple myeloma. Eliquis is an oral inhibitor to reduce stroke risk/systemic embolism (NVAF) and can be used for treatment of DVT/PE. Opdivo has anti-cancer indications. Pomalyst/Imnovid is indicated for multiple myeloma patients. Orencia, for adults with active RA or psoriatic arthritis, are some of the products. Sprycel is available for treatment of Philadelphia chromosome positive chronic myeloidleukemia. Yervoy can be used to treat patients suffering from unresectable, metastatic melanoma. Abraxane is a protein-bound chemotherapy drug. Reblozyl can also be used for treatment of anemia in adults with beta thalassemia. Empliciti treats multiple myeloma. The company also offers Zeposia, which can be used to treat multiple sclerosis relapsing; Breyanzi (a CD19-directed genetically-modified autologous T-cell immunotherapy that treats adult patients suffering from relapsed large B-cell lymphoma); Inrebic, which is an oral kinase inhibitor, for treatment of myelofibrosis patients; and Onureg, for treatment of AML patients. The company sells its products to pharmacies and wholesalers as well as hospitals, clinics, government agencies, pharmacists, doctors, pharmacies, retail outlets, pharmacies, pharmacy chains, hospital staff, and other healthcare providers. The former name of the company was Bristol-Myers Company. It was established in 1887. The headquarters are located in New York, New York.
Earnings Per Share
As for profitability, Bristol has a trailing twelve months EPS of $-2.76.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.09%.Growth Estimates Quarters
The company's growth estimates for the present quarter and the next is a negative 7.5% and a negative 3.8%, respectively.Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Bristol's stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Bristol's stock is valued at $77.54 at 09:24 EST, below its 52-week high of $80.59 and way higher than its 52-week low of $53.22.
More news about Bristol.